Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

1.70
Delayed Data
As of Sep 01
 +0.16 / +10.39%
Today’s Change
1.10
Today|||52-Week Range
7.22
-54.91%
Year-to-Date
No recent news for Caladrius Biosciences Inc.

Today’s Trading

Previous close1.54
Today’s open1.53
Day’s range1.53 - 1.72
Volume477,914
Average volume (3 months)462,703
Market cap$85.2M
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)+11.58%
Earnings growth (this year)--
Earnings growth (next 5 years)+42.90%
Revenue growth (last year)+22.30%
P/E ratioNM
Price/Sales6.88
Price/Book0.97

Competitors

 Today’s
change
Today’s
% change
CDNACareDx Inc+0.05+0.72%
ONCSOncoSec Medical Inc+0.39+7.25%
PMDPsychemedics Corp+0.07+0.63%
CPHRCipher Pharmaceutica...-0.24-4.44%
Data as of 3:59pm ET, 09/01/2015

Financials

Next reporting dateNovember 13, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$17.9M
Annual profit (last year)-$54.9M
Net profit margin-305.89%

Profile

Sector
Distribution Services
Industry
Wholesale Distributors
Chief Executive Officer &
Director
David J. Mazzo
President, Chief Financial Officer &
Director
Robert S. Vaters
Corporate headquarters
New York, New York

Forecasts

Partner Offers